drugset / Trial / NCT00418262
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
NaSingle-groupOpen-labelTreatment
Summary
Determine if atomoxetine is safe and well tolerated by children with fetal alcohol syndrome.
Timeline
- Start
- 2005-08
- Primary completion
- 2015-04-22
- Completion
- 2015-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 0.25 mg/kg | Oral |
| Subject | Atomoxetine | Other / unclassified | 0.5 mg/kg | Oral |
| Subject | Atomoxetine | Other / unclassified | 1 mg/kg | Oral |
| Subject | Atomoxetine | Other / unclassified | 1.4 mg/kg | Oral |